How my CAR-T therapy research seeks to improve cancer care and empower nurses
Emma Williams Haematology trials unit manager, Haematology clinical research group, University Hospital of Wales, Cardiff
Emma Williams’ research into CAR-T therapy for people with relapsed and refractory diffuse large B cell lymphoma hopes to improve knowledge of the cancer treatment and underline the importance of nurse research
No one could have prepared nurses for the widespread destruction that COVID-19 would have on our health organisations with our whole way of working literally changing overnight.
Nurse Researcher.
30, 2, 6-7.
doi: 10.7748/nr.30.2.6.s2
Want to read more?
Already have access? Log in
or
3-month trial offer for £5.25/month
Subscribe today and save 50% on your first three months
RCNi Plus users have full access to the following benefits:
- Unlimited access to all 10 RCNi Journals
- RCNi Learning featuring over 175 modules to easily earn CPD time
- NMC-compliant RCNi Revalidation Portfolio to stay on track with your progress
- Personalised newsletters tailored to your interests
- A customisable dashboard with over 200 topics
Subscribe
Alternatively, you can purchase access to this article for the next seven days.
Buy now
Are you a student? Our student subscription has content especially for you.
Find out more
